Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by bionicjoeon Jun 15, 2019 12:44pm
40 Views
Post# 29828967

RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

RE:RE:RE:RE:RE:RE:200,000 Warrants Converted
Claridge wrote: For a guy that used to bash many posts/day, every single day under different aliases, you'd think he would come more prepared!

Strange (and funny at the sametime) that our clown BionicJoke:

- is silencing our higher efficacy ratios,
- is silencing our last 2 cancer free patients @12 month in one 1-hour treatment,
- is silencing the technology that allows them to see "live" whether or not cancer cells are all destroyed (Dr. Rueck's technology behind that optimized procedure),
- is silencing that we're still authorized by HC (and soon FDA) to enroll less patients, compared to immuno-therapy drugs trials, 
- is silencing the fact that we will not be required to do costly and time consuming Ph. 3!

Thought the clown was too old to post on SH, as per his own saying!
 

 



Don't know what you are referring to bencro with this " silencing " attack on me but do you really want me to respond? I don't think you could handle it.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities